Blindrecalc - an R package for blinded sample size recalculation

Besides the type 1 and type 2 error rate and the clinically relevant effect size, the sample size of a clinical trial depends on so-called nuisance parameters for which the concrete values are usually unknown when a clinical trial is planned. When the uncertainty about the magnitude of these paramet...

Full description

Saved in:
Bibliographic Details
Main Authors: Baumann, Lukas (Author) , Pilz, Maximilian (Author) , Kieser, Meinhard (Author)
Format: Article (Journal)
Language:English
Published: June 21, 2022
In: The R journal
Year: 2022, Volume: 14, Issue: 1, Pages: 137-145
ISSN:2073-4859
DOI:10.32614/RJ-2022-001
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.32614/RJ-2022-001
Get full text
Author Notes:by Lukas Baumann, Maximilian Pilz, and Meinhard Kieser
Description
Summary:Besides the type 1 and type 2 error rate and the clinically relevant effect size, the sample size of a clinical trial depends on so-called nuisance parameters for which the concrete values are usually unknown when a clinical trial is planned. When the uncertainty about the magnitude of these parameters is high, an internal pilot study design with a blinded sample size recalculation can be used to achieve the target power even when the initially assumed value for the nuisance parameter is wrong. In this paper, we present the R-package blindrecalc that helps with planning a clinical trial with such a design by computing the operating characteristics and the distribution of the total sample size under different true values of the nuisance parameter. We implemented methods for continuous and binary outcomes in the superiority and the non-inferiority setting.
Item Description:Gesehen am 21.12.2022
Physical Description:Online Resource
ISSN:2073-4859
DOI:10.32614/RJ-2022-001